Lesch–Nyhan disease and the basal ganglia

The purpose of this review is to summarize emerging evidence that the neurobehavioral features of Lesch-Nyhan disease (LND), a developmental disorder caused by congenital deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT), may be attributable to dysfunction of the basal ganglia. Affected individuals have severe motor disability described by prominent extrapyramidal features that are characteristic of dysfunction of the motor circuits of the basal ganglia. They also display disturbances of ocular motility, cognition, and behavioral control that may reflect disruption of other circuits of the basal ganglia. Though neuropathologic studies of autopsy specimens have revealed no obvious neuroanatomical abnormalities in LND, neurochemical studies have demonstrated 60-90% reductions in the dopamine content of the basal ganglia. In addition, recent PET studies have documented significant reductions in dopamine transporters and [18F]fluorodopa uptake in the basal ganglia. These findings support the proposal that many of the neurobehavioral features of LND might be related to dysfunction of the basal ganglia.

[1]  I. Kopin.  Neurotransmitters and the Lesch-Nyhan syndrome. , 1981, The New England journal of medicine.

[2]  R. Watts,et al.  Use of phytohaemagglutinin stimulated lymphocytes to study effects of hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency on polynucleotide and protein synthesis in the Lesch-Nyhan syndrome. , 1976, Journal of medical genetics.

[3]  Mario F. Mendez,et al.  Neurobehavioral changes associated with caudate lesions , 1989, Neurology.

[4]  A. Straube,et al.  Saccades in gilles de la tourette's syndrome , 1997, Movement disorders : official journal of the Movement Disorder Society.

[5]  J. Rothstein,et al.  Influence of Age and Strain on Striatal Dopamine Loss in a Genetic Mouse Model of Lesch‐Nyhan Disease , 1999, Journal of neurochemistry.

[6]  R. Levine,et al.  Cervical spondylosis and dyskinesias , 1970, Neurology.

[7]  Sergi Ferré,et al.  Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia , 1997, Trends in Neurosciences.

[8]  J. Oliver,et al.  Uptake and supply of purine compounds by the liver. , 1975, The American journal of physiology.

[9]  G. H. Reem.  Phosphoribosylpyrophosphate overproduction, a new metabolic abnormality in the Lesch Nyhan syndrome , 1975, Science.

[10]  J. Seegmiller,et al.  Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency in Gout , 1969 .

[11]  R. Uitti,et al.  Pathogenesis of idiopathic parkinsonism. , 1993, European neurology.

[12]  B. Lynch,et al.  Recurrent coma and Lesch-Nyhan syndrome. , 1991, Pediatric neurology.

[13]  S. Tsuji,et al.  Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene , 1994, Nature Genetics.

[14]  S. Lehéricy,et al.  Striatopallidal and thalamic dystonia. A magnetic resonance imaging anatomoclinical study. , 1996, Archives of neurology.

[15]  J. Joyce,et al.  Functional and Molecular Differentiation of the Dopamine System Induced by Neonatal Denervation , 1996, Neuroscience & Biobehavioral Reviews.

[16]  Norbert Kathmann,et al.  Characteristics of obsessive–compulsive symptoms in Tourette's syndrome, obsessive–compulsive disorder, and Parkinson's disease , 1997, Psychiatry Research.

[17]  Neurobehavioral changes with caudate lesions , 1989, Neurology.

[18]  A. Howell,et al.  Observations on the growth in vitro of myeloid progenitor cells and fibroblasts from hemizygotes and heterozygotes for "complete" and "partial" hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency, and their relevance to the pathogenesis of brain damage in the Lesch-Nyhan syndrome. , 1974, Journal of the neurological sciences.

[19]  L. Pollak,et al.  Neurosurgical intervention for cervical disk disease in dystonic cerebral palsy , 1998, Movement disorders : official journal of the Movement Disorder Society.

[20]  A. Grace,et al.  Compensations after lesions of central dopaminergic neurons: some clinical and basic implications , 1990, Trends in Neurosciences.

[21]  Henderson Jf.  Possible functions of hypoxanthine-guanine phosphoribosyltransferase and their relation to the biochemical pathology of the Lesch-Nyhan syndrome. , 1968 .

[22]  S. Kmoch,et al.  Urinary pterins in Lesch-Nyhan syndrome. , 1991, Advances in Experimental Medicine and Biology.

[23]  M. L. Greene.  Clinical features of patients with the "partial" deficiency of the X-linked uricaciduria enzyme. , 1972, Archives of internal medicine.

[24]  A. Bradley,et al.  Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Dasheiff.  BENZODIAZEPINE TREATMENT FOR LESCH‐NYHAN SYNDROME? , 1980, Developmental medicine and child neurology.

[26]  W. Michener.  Hyperuricemia and mental retardation with athetosis and self-mutilation. , 1967, American journal of diseases of children.

[27]  W. Nyhan,et al.  A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION. , 1964, The American journal of medicine.

[28]  R. Hardie.  Acanthocytosis and neurological impairment--a review. , 1989, The Quarterly journal of medicine.

[29]  B. Dubois,et al.  Do cognitive changes of Parkinson's disease result from dopamine depletion? , 1995, Journal of neural transmission. Supplementum.

[30]  G. Breese,et al.  6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. , 1987, The Journal of pharmacology and experimental therapeutics.

[31]  Y. Agid,et al.  Saccade disturbances after bilateral lentiform nucleus lesions in humans. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[32]  W. Nyhan,et al.  The spectrum of HPRT deficiency: an update. , 1989, Advances in experimental medicine and biology.

[33]  T. Heffner,et al.  Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion , 1981, Brain Research.

[34]  J. Fletcher,et al.  Neuropsychological characteristics of children with Tourette syndrome: evidence for a nonverbal learning disability? , 1994, Journal of clinical and experimental neuropsychology.

[35]  A. Gedye.  Serotonin-GABA treatment is hypothesized for self-injury in Lesch-Nyhan syndrome. , 1992, Medical hypotheses.

[36]  K. Raivio,et al.  Role of glutamine in purine synthesis and in guanine nucleotide formation in normal fibroblasts and in fibroblasts deficient in hypoxanthine phosphoribosyltransferase activity. , 1973, Biochimica et biophysica acta.

[37]  Wolfram Schultz,et al.  Depletion of dopamine in the striatum as an experimental model of parkinsonism: direct effects and adaptive mechanisms , 1982, Progress in Neurobiology.

[38]  D. Muzny,et al.  The Chinese hamster HPRT gene: restriction map, sequence analysis, and multiplex PCR deletion screen. , 1991, Genomics.

[39]  L. Birnbaumer,et al.  G proteins in signal transduction. , 1990, Annual review of pharmacology and toxicology.

[40]  B. Pappas,et al.  Early behavioral and catecholaminergic effects of 6-hydroxydopamine and guanethidine in the neonatal rat , 1975, Pharmacology Biochemistry and Behavior.

[41]  M Cascante,et al.  Analysis of abnormalities in purine metabolism leading to gout and to neurological dysfunctions in man. , 1998, The Biochemical journal.

[42]  M. Ernst,et al.  Presynaptic dopaminergic deficits in Lesch-Nyhan disease. , 1996, The New England journal of medicine.

[43]  L. H. Dizmang,et al.  The Lesch-Nyhan syndrome. , 1970, American Journal of Psychiatry.

[44]  Y. Yugari,et al.  Prophylactic Effect of L-5-Hydroxytryptophan on Self-Mutilation in the Lesch-Nyhan Syndrome , 1975 .

[45]  S. Kish,et al.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.

[46]  Yael Bromberg,et al.  Characterization of the Alterations in Purine Nucleotide Metabolism in Hypoxanthine‐Guardne Phosphoribosyltransferase‐Deficient Rat Neuroma Cell Line , 1993, Journal of neurochemistry.

[47]  J. Jankovic,et al.  and J Jankovic The alien hand and related signs , 2022 .

[48]  A. Luria.  The Working Brain: An Introduction To Neuropsychology , 1976 .

[49]  D J Brooks,et al.  Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease. , 1996, Brain : a journal of neurology.

[50]  D. Pelled,et al.  Abnormal Purine and Pyrimidine Nucleotide Content in Primary Astroglia Cultures from Hypoxanthine—Guanine Phosphoribosyltransferase‐Deficient Transgenic Mice , 1999, Journal of neurochemistry.

[51]  M. Beal,et al.  Aging, energy, and oxidative stress in neurodegenerative diseases , 1995, Annals of neurology.

[52]  G. Arbuthnott,et al.  Analysis of forebrain dopaminergic pathways in HPRT-mice. , 1991, Advances in experimental medicine and biology.

[53]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[54]  E. Chee,et al.  Volumetric MRI changes in basal ganglia of children with Tourette's syndrome , 1993, Neurology.

[55]  B. V. D. van de Wetering,et al.  Oculomotor control in Gilles de la Tourette syndrome. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[56]  Thorpe Wp.  The Lesch-Nyhan syndrome. , 1971 .

[57]  P. Mcguire,et al.  The brain in obsessive-compulsive disorder. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[58]  S. Fahn,et al.  The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it , 1992, Annals of neurology.

[59]  J. Dancis,et al.  Congenital hyperuricemia. An inborn error of purine metabolism associated with psychomotor retardation, athetosis, and self-mutilation. , 1969, Archives of neurology.

[60]  G. Breese,et al.  Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. , 1984, The Journal of pharmacology and experimental therapeutics.

[61]  R. Leigh,et al.  The neurology of eye movements , 1984 .

[62]  W. Nyhan,et al.  Hypoxanthine and tetrahydrobiopterin treatment of a patient with features of the Lesch-Nyhan syndrome. , 1986 .

[63]  W. Matthews,et al.  COGNITIVE FUNCTIONING IN LESCH‐NYHAN SYNDROME , 1995, Developmental medicine and child neurology.

[64]  B. Mitchell,et al.  Z-nucleotide accumulation in erythrocytes from Lesch-Nyhan patients. , 1985 .

[65]  A. Graybiel.  Neurotransmitters and neuromodulators in the basal ganglia , 1990, Trends in Neurosciences.

[66]  C Kennard,et al.  Oculomotor abnormalities in diseases of the basal ganglia. , 1989, Revue neurologique.

[67]  W. H. Church,et al.  Uric acid is reduced in the substantia nigra in parkinson's disease: Effect on dopamine oxidation , 1994, Brain Research Bulletin.

[68]  J. Penney,et al.  Speculations on the functional anatomy of basal ganglia disorders. , 1983, Annual review of neuroscience.

[69]  P. Calabresi,et al.  The neostriatum beyond the motor function: experimental and clinical evidence. , 1997, Neuroscience.

[70]  P. Gasquoine.  Alien hand sign. , 1993, Journal of Clinical and Experimental Neuropsychology.

[71]  R. Watts,et al.  Activities of amidophosphoribosyltransferase (EC 2.4.2.14) and the purine phosphoribosyltransferases (EC 2.4.2.7 and 2.4.2.8), and the phosphoribosylpyrophosphate content of rat central nervous system at different stages of development Their possible relationship to the neurological dysfunction in t , 1980, Journal of the Neurological Sciences.

[72]  J. Seegmiller,et al.  Inherited disorder of purine metabolism. Correlation between central nervous system dysfunction and biochemical defects. , 1967, JAMA.

[73]  I H Fox,et al.  Adenine nucleotide turnover in hypoxanthine-guanine phosphoribosyl-transferase deficiency: evidence for an increased contribution of purine biosynthesis de novo. , 1989, Metabolism: clinical and experimental.

[74]  B Mazoyer,et al.  Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study. , 1989, Brain : a journal of neurology.

[75]  J. Cummings,et al.  Neuro‐opthalmic abnormalities in Tourette's syndrome , 1984, Neurology.

[76]  M. Johnston,et al.  Lesch‐Nyhan syndrome , 1985, Neurology.

[77]  A. Gilman,et al.  G proteins: transducers of receptor-generated signals. , 1987, Annual review of biochemistry.

[78]  F. Goodwin,et al.  Identification of inosine and hypoxanthine as endogenous inhibitors of [3H] diazepam binding in the central nervous system. , 1978, Life sciences.

[79]  Seegmiller Je,et al.  Preventive control of the Lesch-Nyhan syndrome. , 1972 .

[80]  R. Tomlinson,et al.  Ocular motor deficits in Parkinson's disease. II. Control of the saccadic and smooth pursuit systems. , 1983, Brain : a journal of neurology.

[81]  R. O. Mckeran.  Factors in the pathogenesis of the brain damage and anaemia in the Lesch-Nyhan syndrome. , 1977, Ciba Foundation symposium.

[82]  T. Friedmann,et al.  Brain Purines in a Genetic Mouse Model of Lesch‐Nyhan Disease , 1993, Journal of neurochemistry.

[83]  L. Scahill,et al.  Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome. , 1995, Advances in neurology.

[84]  R. Watts,et al.  Clinical, post-mortem, biochemical and therapeutic observations on the Lesch-Nyhan syndrome with particular reference to the Neurological manifestations. , 1982, The Quarterly journal of medicine.

[85]  K. Fuxe,et al.  Adenosine-dopamine interactions in the brain , 1992, Neuroscience.

[86]  T. Friedmann,et al.  Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[87]  M. Holdeigel.  [Cranial computerized tomography in incomplete Lesch-Nyhan syndrome]. , 1987, Der Radiologe.

[88]  F. Gabreëls,et al.  Biochemical hallmarks of tyrosine hydroxylase deficiency. , 1998, Clinical chemistry.

[89]  A. Thompson,et al.  Atlantoaxial Instability in Lesch‐Nyhan Syndrome , 1996, Spine.

[90]  M. Trimble,et al.  Self-injurious behaviour and the Gilles de la Tourette syndrome: a clinical study and review of the literature , 1989, Psychological Medicine.

[91]  W. Nyhan,et al.  A familial disorder of uric acid metabolism and central nervous system function. II , 1965 .

[92]  K. Raivio,et al.  Lesch-Nyhan Syndrome: Preventive Control by Prenatal Diagnosis , 1970, Science.

[93]  A. Bradley,et al.  A potential animal model for Lesch–Nyhan syndrome through introduction of HPRT mutations into mice , 1987, Nature.

[94]  B. Vogt,et al.  Contributions of anterior cingulate cortex to behaviour. , 1995, Brain : a journal of neurology.

[95]  R. Strub,et al.  Frontal lobe syndrome in a patient with bilateral globus pallidus lesions. , 1989, Archives of neurology.

[96]  J. Seegmiller,et al.  Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase. , 1968, The Journal of biological chemistry.

[97]  L. Anderson,et al.  Self-injury in Lesch-Nyhan disease , 1994, Journal of autism and developmental disorders.

[98]  G C Curtis,et al.  Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. , 1989, The Journal of neuropsychiatry and clinical neurosciences.

[99]  Y. Smith,et al.  Microcircuitry of the direct and indirect pathways of the basal ganglia. , 1998, Neuroscience.

[100]  G. Nuki,et al.  Biochemical characteristics of 8-azaguanine resistant human lymphoblast mutants selected in vitro. , 1973, Advances in experimental medicine and biology.

[101]  M. Bull,et al.  Behavior Therapy for a Child with Lesch‐Nyhan Syndrome , 1978, Developmental medicine and child neurology.

[102]  M. Segraves,et al.  Acute activation and inactivation of macaque frontal eye field with GABA-related drugs. , 1995, Journal of neurophysiology.

[103]  J. Cummings.  Frontal-subcortical circuits and human behavior. , 1993, Journal of psychosomatic research.

[104]  D. Schretlen,et al.  Neurocognitive functioning in Lesch-Nyhan disease and partial hypoxanthine-guanine phosphoribosyltransferase deficiency , 2001, Journal of the International Neuropsychological Society.

[105]  R. D. Green,et al.  Modulation of striatal dopaminergic function by local injection of 5'-N-ethylcarboxamide adenosine. , 1982, Science.

[106]  R. Ridley,et al.  The psychology of perseverative and stereotyped behaviour , 1994, Progress in Neurobiology.

[107]  M. L. Stagnitto,et al.  Anticonvulsant Properties of Calcium Channel Blockers in Mice: N‐Methyl‐D‐, L‐Aspartate‐ and Bay K 8644‐Induced Convulsions are Potently Blocked by the Dihydropyridines , 1993, Epilepsia.

[108]  T. Insel,et al.  Toward a neuroanatomy of obsessive-compulsive disorder. , 1992, Archives of general psychiatry.

[109]  U. Francke,et al.  Utilization of Purines by an HPRT Variant in an Intelligent, Nonmutilative Patient with Features of the Lesch-Nyhan Syndrome , 1979, Pediatric Research.

[110]  H. Singer,et al.  Tourette Syndrome and Other Tic Disorders Diagnosis, Pathophysiology, and Treatment , 1991, Medicine.

[111]  R. Laessig,et al.  Adenine and Folic Acid in the Lesch-Nyhan Syndrome , 1973, Pediatric Research.

[112]  S. Folstein,et al.  Saccades in Huntington's disease , 1987, Neurology.

[113]  H. Itabashi,et al.  Juvenile gout with brain involvement. , 1965, Archives of neurology.

[114]  A. Parent,et al.  The current model of basal ganglia organization under scrutiny , 1998, Movement disorders : official journal of the Movement Disorder Society.

[115]  K. Ono,et al.  The cervical spine in athetoid cerebral palsy. A radiological study of 180 patients. , 1996, The Journal of bone and joint surgery. British volume.

[116]  Bornstein Ra.  Neuropsychological performance in adults with Tourette's syndrome. , 1991 .

[117]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[118]  B. Howard,et al.  Dopamine Metabolism in Hypoxanthine‐Guanine Phosphoribosyltransferase‐Deficient Variants of PC12 Cells , 1986, Journal of neurochemistry.

[119]  T. Stone.  Physiological roles for adenosine and adenosine 5′-triphosphate in the nervous system , 1981, Neuroscience.

[120]  C. Olanow.  A radical hypothesis for neurodegeneration , 1993, Trends in Neurosciences.

[121]  A. Baumeister,et al.  Self-Injurious Behavior , 1976 .

[122]  S. Takashima,et al.  Dopamine receptor upregulation in Lesch-Nyhan syndrome: a postmortem study. , 1999, Neuropediatrics.

[123]  D. Comings.  Tourette's syndrome: a behavioral spectrum disorder. , 1995, Advances in neurology.

[124]  B. Shaywitz,et al.  Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine , 1976, Nature.

[125]  R. Bornstein.  Neuropsychological performance in children with Tourette's syndrome , 1990, Psychiatry Research.

[126]  Alan C. Evans,et al.  Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[127]  C. Marsden,et al.  The behavioural and motor consequences of focal lesions of the basal ganglia in man. , 1994, Brain : a journal of neurology.

[128]  M. Stanley,et al.  Self-injurious behavior: a review of the behavior and biology of self-mutilation. , 1991, The American journal of psychiatry.

[129]  W. Nyhan,et al.  Clinical correlations in partial hypoxanthine guanine phosphoribosyltransferase deficiency. , 1986, Pediatric neurology.

[130]  M. Beal,et al.  Bioenergetic and oxidative stress in neurodegenerative diseases. , 1995, Life sciences.

[131]  Y. Agid,et al.  Eye movements in parkinsonian syndromes , 1994, Annals of neurology.

[132]  W. Berndt,et al.  HEREDITARY CHOREOATHETOSIS, SELF-MUTILATION AND HYPERURICEMIA IN YOUNG MALES. , 1965, The New England journal of medicine.

[133]  G. E. Alexander.  Basal Ganglia‐Thalamocortical Circuits: Their Role in Control of Movements , 1994, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[134]  W. Nyhan,et al.  Lesch‐Nyhan Disease: Clinical Experience with Nineteen Patients , 1982 .

[135]  W. Nyhan,et al.  Behavior in the Lesch-Nyhan syndrome , 1976, Journal of autism and childhood schizophrenia.

[136]  A. Afifi,et al.  Topical Review: Basal Ganglia: Functional Anatomy and Physiology. Part 2 , 1994, Journal of child neurology.

[137]  H. Erfle,et al.  Automated DNA sequencing of the human HPRT locus. , 1990, Genomics.

[138]  A. Kačar,et al.  Symptomatic Dystonias Associated with Structural Brain Lesions: Report of 16 Cases , 1996, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[139]  R. Surtees,et al.  Aromatic L‐amino acid decarboxylase deficiency , 1992, Neurology.

[140]  K. Ullrich,et al.  A case of Lesch Nyhan syndrome with delayed onset of self-mutilation: search for abnormal biochemical, immunological and cell growth characteristic in fibroblasts and neurotransmitters in urine. , 1986 .

[141]  Christopher A Ross,et al.  Widespread expression of Huntington's disease gene (IT15) protein product , 1995, Neuron.

[142]  A. Parent,et al.  Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidium in basal ganglia circuitry , 1995, Brain Research Reviews.

[143]  R. Bryan,et al.  Craniocerebral magnetic resonance imaging measurement and findings in Lesch-Nyhan syndrome. , 1998, Archives of neurology.

[144]  B. Shaywitz,et al.  Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. , 1976, Science.

[145]  F. Gage,et al.  Localization of hypoxanthine-guanine phosphoribosyltransferase mRNA in the mouse brain by in situ hybridization , 1992, Molecular and Cellular Neuroscience.

[146]  D. Stuss,et al.  Neuropsychological studies of the frontal lobes. , 1984, Psychological bulletin.

[147]  F. Pellicer,et al.  Self-mutilation in the Lesch-Nyhan syndrome: a corporal consciousness problem?--a new hypothesis. , 1998, Medical hypotheses.

[148]  B. Ames,et al.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[149]  M. Jarvis,et al.  Adenosine and dopamine function in the CNS , 1987 .

[150]  D. Comings,et al.  A controlled study of Tourette syndrome. IV. Obsessions, compulsions, and schizoid behaviors. , 1987, American journal of human genetics.

[151]  D. Robertson,et al.  The pathological condition of Lesch-Nyhan syndrome. Report of two cases. , 1969, American journal of diseases of children.

[152]  S. Folstein,et al.  Abnormal ocular motor control in Huntington's disease , 1983, Neurology.

[153]  B. King.  Self-injury by people with mental retardation: a compulsive behavior hypothesis. , 1993, American journal of mental retardation : AJMR.

[154]  H. Itabashi,et al.  Cervical spondylosis in patients with athetosis , 1962, Neurology.

[155]  F R Ervin,et al.  Hypoxanthine accumulation and dopamine depletion in Lesch-Nyhan disease. , 1989, Advances in experimental medicine and biology.

[156]  A. Scherzer,et al.  Normal intelligence in the Lesch-Nyhan syndrome. , 1969, Pediatrics.

[157]  W. Nyhan,et al.  Self-mutilative behavior as a feature of the de Lange syndrome. , 1971, The Journal of pediatrics.

[158]  C. Marsden,et al.  The anatomical basis of symptomatic hemidystonia. , 1985, Brain : a journal of neurology.

[159]  W. Nyhan,et al.  Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome , 1979, Journal of autism and developmental disorders.

[160]  T. Feinberg,et al.  Two alien hand syndromes , 1992, Neurology.

[161]  G. E. Alexander,et al.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.

[162]  Okihide Hikosaka.  Role of basal ganglia in saccades. , 1989, Revue neurologique.

[163]  R. D. Hunt,et al.  Huntington's dementia. Clinical and neuropsychological features. , 1978, Archives of general psychiatry.

[164]  F. Gage,et al.  Animal models of Lesch-Nyhan syndrome , 1990, Brain Research Bulletin.

[165]  J. Mink.  THE BASAL GANGLIA: FOCUSED SELECTION AND INHIBITION OF COMPETING MOTOR PROGRAMS , 1996, Progress in Neurobiology.

[166]  B. Hennen,et al.  The Lesch‐Nyhan Syndrome: Self‐Destructive Biting, Mental Retardation, Neurological Disorder and Hyperuricaemia , 1967, Developmental medicine and child neurology.

[167]  T. Robinson,et al.  Dopamine depletion in neonatal rats: effects on behavior and striatal dopamine release assessed by intracerebral microdialysis during adulthood , 1990, Brain Research.

[168]  C. Kellner,et al.  Obsessive-compulsive symptoms in neurologic disease: a review. , 1992, Behavioural neurology.

[169]  J. Jankovic,et al.  Lesch‐nyhan syndrome: A study of motor behavior and cerebrospinal fluid neurotransmitters , 1988, Annals of neurology.

[170]  J. Friedman,et al.  Cervical stenosis and dystonic cerebral palsy , 1999, Movement disorders : official journal of the Movement Disorder Society.

[171]  B. Peterson,et al.  Reduced basal ganglia volumes in Tourette's syndrome using three‐dimensional reconstruction techniques from magnetic resonance images , 1993, Neurology.

[172]  J. Baum,et al.  Lesch-Nyhan syndrome treated from the early neonatal period. , 1968, Pediatrics.

[173]  D. Comings,et al.  Tourette syndrome: clinical and psychological aspects of 250 cases. , 1985, American journal of human genetics.

[174]  I. Shoulson,et al.  Clinical‐pathologic correlation in Huntington's disease , 1989, Neurology.

[175]  M. Monk,et al.  HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells , 1987, Nature.

[176]  JohannesP. W. F. Lakke,et al.  Classification of extrapyramidal disorders , 1981, Journal of the Neurological Sciences.

[177]  M. Chesselet,et al.  Basal ganglia and movement disorders: an update , 1996, Trends in Neurosciences.

[178]  S. Finger,et al.  Behavioral and neurochemical evaluation of a transgenic mouse model of Lesch-Nyhan syndrome , 1988, Journal of the Neurological Sciences.

[179]  W. Nyhan,et al.  Behavioral Phenotypes in Organic Genetic Disease: Presidential Address to the Society for Pediatric Research, May 1, 1971 , 1972, Pediatric Research.

[180]  H. Moldofsky,et al.  Multiple tic syndrome (Giles de la Tourette's syndrome). , 1974, The Journal of nervous and mental disease.

[181]  R. A. Harkness,et al.  Developmental changes in purine phosphoribosyltransferases in human and rat tissues. , 1976, The Biochemical journal.

[182]  T. Skopek,et al.  Germinal HPRT splice donor site mutation results in multiple RNA splicing products in T-lymphocyte cultures , 1996, Somatic cell and molecular genetics.

[183]  D. R. Weinberger,et al.  Cerebral morphometric abnormalities in Tourette's syndrome , 1995, Neurology.

[184]  K. Shannak,et al.  Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. , 1981, The New England journal of medicine.

[185]  J. Friedman.  Punding on levodopa , 1994, Biological Psychiatry.

[186]  R. Palmour.  Animal Models for Lesch-Nyhan Disease , 1992 .

[187]  R. Kurlan,et al.  Neurosurgical treatment of severe obsessive‐compulsive disorder associated with Tourette's syndrome , 1990, Movement disorders : official journal of the Movement Disorder Society.

[188]  J. Deniau,et al.  Disinhibition as a basic process in the expression of striatal functions , 1990, Trends in Neurosciences.

[189]  S. Kish,et al.  Brain benzodiazepine receptor binding and purine concentration in Lesch-Nyhan syndrome , 1985, Brain Research.

[190]  J. Kulisevsky,et al.  Obsessive-compulsive disorder associated with brain lesions , 1996, Neurology.

[191]  R. Watts.  Defects of tetrahydrobiopterin synthesis and their possible relationship to a disorder of purine metabolism (the Lesch-Nyhan syndrome). , 1985, Advances in enzyme regulation.

[192]  C. Kennard,et al.  Predictive ocular motor control in Parkinson's disease. , 1985, Brain : a journal of neurology.

[193]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[194]  M. Brin,et al.  Perioperative use of botulinum toxin for movement disorder–induced cervical spine disease , 1996, Movement disorders : official journal of the Movement Disorder Society.

[195]  S. Dunnett,et al.  Monoamine deficiency in a transgenic (Hprt− ) mouse model of Lesch-Nyhan syndrome , 1989, Brain Research.

[196]  J. Yeh,et al.  Impaired differentiation of HPRT‐deficient dopaminergic neurons: A possible mechanism underlying neuronal dysfunction in Lesch‐Nyhan syndrome , 1998, Journal of neuroscience research.

[197]  G. E. Alexander,et al.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.

[198]  J. Krauss,et al.  Severe motor tics causing cervical myelopathy in Tourette's syndrome , 1996, Movement disorders : official journal of the Movement Disorder Society.

[199]  J. Penney,et al.  The functional anatomy of disorders of the basal ganglia , 1995, Trends in Neurosciences.

[200]  G. Avanzini,et al.  Oculomotor disorders in Huntington's chorea. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[201]  D. Comings,et al.  A controlled study of Tourette syndrome. VII. Summary: a common genetic disorder causing disinhibition of the limbic system. , 1987, American journal of human genetics.

[202]  C. Harris,et al.  Eyemovement abnormalities in a case of Tourette syndrome , 1997, Developmental medicine and child neurology.

[203]  D. Granger,et al.  Xanthine oxidase: biochemistry, distribution and physiology. , 1986, Acta physiologica Scandinavica. Supplementum.

[204]  Y. Wada,et al.  Lesch-Nyhan syndrome: autopsy findings and in vitro study of incorporation of 14C-8-inosine into uric acid, guanosine-monophosphate and adenosine-monophosphate in the liver. , 1968, The Tohoku journal of experimental medicine.

[205]  K Yonenobu,et al.  Unstable Cervical Spine in Athetoid Cerebral Palsy , 1989, Spine.

[206]  T. Mizuno.  Long-Term Follow-Up of Ten Patients with Lesch-Nyhan Syndrome , 1986, Neuropediatrics.

[207]  A. Parent,et al.  Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop , 1995, Brain Research Reviews.

[208]  G. Breese,et al.  Neonatal-6-hydroxydopamine treatment: Model of susceptibility for self-mutilation in the lesch-nyhan syndrome , 1984, Pharmacology Biochemistry and Behavior.

[209]  D. Palumbo,et al.  Hypothesis III. Tourette syndrome is only one of several causes of a developmental basal ganglia syndrome. , 1997, Archives of neurology.

[210]  W. Nyhan.  Clinical features of the Lesch-Nyhan syndrome. , 1972, Archives of internal medicine.

[211]  H. Jinnah,et al.  Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome. , 1992, The Journal of pharmacology and experimental therapeutics.

[212]  S. Kadoya,et al.  Cervical spondylotic radiculo-myelopathy in patients with athetoid-dystonic cerebral palsy: clinical evaluation and surgical treatment. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[213]  S. R. Snodgrass,et al.  Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine , 1986, Pharmacology Biochemistry and Behavior.

[214]  G. Breese,et al.  Differential effects of bilateral dopamine depletion in neonatal and adult rats , 1997, Neuroscience & Biobehavioral Reviews.

[215]  T. Archer,et al.  Neonatal 6-hydroxydopamine-induced dopamine depletions: Motor activity and performance in maze learning , 1988, Pharmacology Biochemistry and Behavior.

[216]  D. Comings,et al.  A controlled study of Tourette syndrome. II. Conduct. , 1987, American journal of human genetics.

[217]  Keshav R. Rao,et al.  Cervical myelopathy secondary to movement disorders: case report. , 1989, Neurosurgery.